Rowan-Virtua SOM and Durin Publish Findings of Blood Test for Diagnosing Alzheimer’s Disease

Time Stamp: March 9, 2023 3:07 PM
Source Node: 2511543

Rowan-Virtua SOM and Durin recently published findings of a blood test that could diagnose Alzheimer’s disease. This is a major breakthrough in the medical field, as it could potentially provide an early diagnosis of the disease and help patients receive treatment sooner.

Alzheimer’s disease is a progressive, degenerative disorder that affects the brain and causes memory loss, confusion, and other cognitive problems. It is the most common form of dementia and currently affects over 5 million Americans. Unfortunately, there is no cure for Alzheimer’s disease and treatments are limited to managing symptoms.

The new blood test developed by Rowan-Virtua SOM and Durin is based on a study of over 1,000 patients. Researchers identified 10 biomarkers in the blood that are associated with Alzheimer’s disease. The test was able to accurately diagnose Alzheimer’s in 87% of cases.

This blood test could be a game-changer for the medical community. It could provide an early diagnosis of Alzheimer’s disease, which would allow patients to receive treatment sooner and potentially slow the progression of the disease. It could also help doctors identify patients who are at risk of developing Alzheimer’s and provide them with preventive care.

The blood test is still in its early stages and more research needs to be done before it can be used in clinical settings. However, the findings of this study are promising and could lead to a more accurate and reliable way to diagnose Alzheimer’s disease.

Rowan-Virtua SOM and Durin’s findings are a major breakthrough in the medical field and could potentially revolutionize the way Alzheimer’s disease is diagnosed and treated. This blood test could provide an early diagnosis of the disease, allowing patients to receive treatment sooner and potentially slow its progression. More research needs to be done before it can be used in clinical settings, but the findings of this study are promising and could lead to a more accurate and reliable way to diagnose Alzheimer’s disease.